<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">TIH</journal-id>
<journal-id journal-id-type="hwp">sptih</journal-id>
<journal-id journal-id-type="nlm-ta">Toxicol Ind Health</journal-id>
<journal-title>Toxicology and Industrial Health</journal-title>
<issn pub-type="ppub">0748-2337</issn>
<issn pub-type="epub">1477-0393</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0748233711416948</article-id>
<article-id pub-id-type="publisher-id">10.1177_0748233711416948</article-id>
<title-group>
<article-title>Synergistic effect of lycopene and tocopherol against oxidative stress and mammary tumorigenesis induced by 7,12-dimethyl[<italic>a</italic>]benzanthracene in female rats</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Al-Malki</surname>
<given-names>Abdulrahman L</given-names>
</name>
<xref ref-type="aff" rid="aff1-0748233711416948">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Moselhy</surname>
<given-names>Said S</given-names>
</name>
<xref ref-type="aff" rid="aff1-0748233711416948">1</xref>
<xref ref-type="aff" rid="aff2-0748233711416948">2</xref>
<xref ref-type="corresp" rid="corresp1-0748233711416948"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Refai</surname>
<given-names>Mohammed Y</given-names>
</name>
<xref ref-type="aff" rid="aff1-0748233711416948">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0748233711416948"><label>1</label>Biochemistry Department, King Abdul-Aziz University, KSA, Jeddah</aff>
<aff id="aff2-0748233711416948"><label>2</label>Ain Shams University, Cairo, Egypt</aff>
<author-notes>
<corresp id="corresp1-0748233711416948">Said S Moselhy, Faculty of Science, Ain Shams University, Cairo 22015, Egypt. Email: <email>moselhy6@hotmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>7</month>
<year>2012</year>
</pub-date>
<volume>28</volume>
<issue>6</issue>
<fpage>542</fpage>
<lpage>548</lpage>
<permissions>
<copyright-statement>© The Author(s) 2011</copyright-statement>
<copyright-year>2011</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Breast cancer is one of the most serious problems in oncology. We investigated the antitumor potential of lycopene (Lyco) alone or combined with tocopherol (Lyco + Toco) for 90 days against a single oral dose of (50 mg/kg body weight) 7,12-dimethyl[<italic>a</italic>]benzanthracene (DMBA)-induced oxidative stress and mammary carcinogenesis in female rats. The treatment protocol started from the day immediately after DMBA administration. Results obtained indicated that there was a significant elevation in the levels of malondialdehyde (MDA) and nitric oxide (NO) in serum and breast tissues of DMBA-injected rats. The combined treatment (Lyco + Toco) group showed a potential reduction of these parameters more than Lyco alone group. The activities of superoxide dismutase, catalase, and glutathione peroxidase were found to be significantly higher when compared to rats treated with Lyco alone. In DMBA group, a positive significant correlation between NO and MDA (<italic>r</italic> = 0.92) was observed. Histopathological examination revealed the formation of tumor and angiogenesis in DMBA-induced rats and these abnormal changes were ameliorated by combined treatment with Lyco + Toco. In conclusion, these results suggested that supplementation of diet with Lyco and Toco provided antioxidant defense, with strong chemopreventive activity against DMBA-induced mammary tumors.</p>
</abstract>
<kwd-group>
<kwd>DMBA</kwd>
<kwd>lycopene</kwd>
<kwd>tocopherol</kwd>
<kwd>breast caner</kwd>
<kwd>rats</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0748233711416948">
<title>Introduction</title>
<p>Breast cancer is one of the most common cancers in women. Worldwide, it is the second most common type of cancer after lung cancer (<xref ref-type="bibr" rid="bibr40-0748233711416948">World Health Organization, 2003</xref>) and the fifth most common cause of cancer death (<xref ref-type="bibr" rid="bibr39-0748233711416948">World Health Organization, 2006</xref>). Reactive oxygen species (ROS) are involved in a variety of important pathophysiological conditions including mutagenesis and carcinogenesis (<xref ref-type="bibr" rid="bibr1-0748233711416948">Aruoma, 1994</xref>; <xref ref-type="bibr" rid="bibr5-0748233711416948">Cerutti, 1985</xref>). Oxidative stress has the potential to cause cellular DNA damage, lipid peroxidation, and membrane disruption (<xref ref-type="bibr" rid="bibr18-0748233711416948">Gilbert and Colton, 1999</xref>). Human body is equipped with various antioxidants such as superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT), glutathione (GSH), ascorbic acid (vitamin C), α-tocopherol (vitamin E), and so on, which can counteract the deleterious action of ROS and protect from cellular and molecular damage (<xref ref-type="bibr" rid="bibr26-0748233711416948">Jagetia and Rao, 2006</xref>).</p>
<p>Bioactive compounds from plant origin have the potential to subside the biochemical imbalances induced by various toxins associated with free radicals. They provide protection without causing any side effects and therefore, development of drugs from plant products is desired. For that account natural antioxidants from plant sources have been viewed as promising therapeutic drugs (<xref ref-type="bibr" rid="bibr36-0748233711416948">Vijayavel et al., 2006</xref>).</p>
<p>Specific nutrients rich in fruits and vegetables, including carotenoids, may play a role in cancer prevention (<xref ref-type="bibr" rid="bibr9-0748233711416948">Clinton, 1998</xref>). Lycopene, the pigment principally responsible for the characteristic deep-red color of ripe tomato fruits and tomato products, has received much attention in recent years because of its beneficial effect in the treatment of diseases (<xref ref-type="bibr" rid="bibr34-0748233711416948">Rao and Agarwal, 1999</xref>). It was demonstrated that lycopene provided the best protection against singlet oxygen-induced cell damage (<xref ref-type="bibr" rid="bibr27-0748233711416948">Joseph et al., 2001</xref>).</p>
<p>Lycopene has been shown to have strong antioxidant properties relative to other carotenoids (<xref ref-type="bibr" rid="bibr36-0748233711416948">Vijayavel et al., 2006</xref>). Recently, lycopene has garnered specific attention over other carotenoids for its potential role in cancer prevention (<xref ref-type="bibr" rid="bibr35-0748233711416948">Sesso, et al. 2005</xref>). Epidemiologic studies revealed that, lycopene may increasingly be identified as sharing inverse relationships to cancer with other common carotenoids or as being the only carotenoid to show such an association (<xref ref-type="bibr" rid="bibr17-0748233711416948">Gerster, 1997</xref>).</p>
<p>Lycopene in human plasma has a half-life of about 2–3 days (<xref ref-type="bibr" rid="bibr9-0748233711416948">Clinton, 1998</xref>). Only a few metabolites, such as 5,6-dihydroxy-5,6-dihydro lycopene, have been detected in human plasma (<xref ref-type="bibr" rid="bibr34-0748233711416948">Rao and Agarwal, 1999</xref>). Owing to its lipophilic nature, lycopene was found in serum low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL) fractions and not in high-density lipoprotein (HDL) (<xref ref-type="bibr" rid="bibr16-0748233711416948">Fuhramn et al., 1997</xref>).</p>
<p>α-Tocopherol is a major lipid-soluble antioxidant vitamin that acts as a free radical scavenger present as an integral component in cellular membranes and having important biological functions (<xref ref-type="bibr" rid="bibr3-0748233711416948">Burton, 1994</xref>). This vitamin is known to protect cellular membranes from oxidative damage and lipid peroxidation (<xref ref-type="bibr" rid="bibr30-0748233711416948">Machlin and Bendich, 1987</xref>). Supplementation of this antioxidant is also reported to decrease oxidative DNA damage (<xref ref-type="bibr" rid="bibr4-0748233711416948">Carpenter, 1991</xref>). α-Tocopherol has been considered to be one of the potential chemopreventive agents for cancer. Experimental studies have revealed the protective effects of this vitamin against the development of sarcomas and carcinomas at different sites. Research on the protective effect of α-tocopherol on carcinogenesis, some experimental studies and human trials are underway (<xref ref-type="bibr" rid="bibr13-0748233711416948">Duthe et al., 1996</xref>).</p>
<p>The primary mechanism by which carotenoids and tocopherols are proposed to prevent cancer is through their antioxidant properties (<xref ref-type="bibr" rid="bibr18-0748233711416948">Gilbert and Colton, 1999</xref>). Our previous study concluded that lycopene-supplemented diet with melatonin provided antioxidant defense, with strong chemopreventive activity against DMBA-induced mammary tumors (<xref ref-type="bibr" rid="bibr32-0748233711416948">Moselhy and Almslmani, 2008</xref>).</p>
<p>The goal of this study was to evaluate the effect of lycopene (Lyco) alone or combined with tocopherol (Lyco + Toco) in inhibiting the oxidative stress and carcinogenic effect of DMBA-induced mammary cancer in rats.</p>
</sec>
<sec id="section2-0748233711416948" sec-type="methods">
<title>Materials and methods</title>
<sec id="section3-0748233711416948">
<title>Experimental animals</title>
<p>The experimental protocol was approved by the animal care committee of King Abdul-Aziz University.</p>
<p>Sixty female adult Sprague Dawley rats, weighing 80–100 g, were purchased from colony of laboratory animals from the King Fahd Medical Research Center, Jeddah, KSA. The rats were housed in steel mesh cages and acclimatized for a 1-week period on commercial pellet diet and drinking water <italic>ad libitum</italic>. Rats were maintained under standard animal house conditions (12:12 h light–dark and 22°C temperature). Rats were randomly divided into 4 groups (15 rats per group), group I: (control). Rats of groups II, III, and IV were administrated intragastrically with a single dose of (50 mg/kg BW) 7,12-dimethyl[<italic>a</italic>]benzanthracene (DMBA, Sigma Chemicals, St Louis, MO, USA). DBMA was dissolved in corn oil and given in a volume of 1 ml (<xref ref-type="bibr" rid="bibr30-0748233711416948">Machlin and Bendich, 1987</xref>). On the day after DMBA administration, rats in group III were fed on diet supplemented with lycopene (50 mg/kg of diet) (<xref ref-type="bibr" rid="bibr23-0748233711416948">Henry and Narendra, 2006</xref>), and rats in group IV were supplemented with lycopene injected orally a dose of 100 mg Toco/kg BW (<xref ref-type="bibr" rid="bibr11-0748233711416948">Das, 1994</xref>). Rats were palpated weekly for tumor appearance. At the end of the experiment (90 days), the rats were killed under anesthesia with diethylether. Blood and breast were collected. Blood was left without anticoagulant for serum separation. Serum and tissues were stored at −20°C until analysis. A part of tissues were collected in 10% formalin for histopathological examination.</p>
<p>The constituents of standard diet are protein (17%), oil (3.5%), fiber (8.5%), moisture (14%), digestible energy (12%), vitamins mixture (1%), and minerals mixture (2.5%).</p>
</sec>
<sec id="section4-0748233711416948">
<title>Biochemical analysis</title>
<sec id="section5-0748233711416948">
<title>Nitric oxide measurement</title>
<p>Serum and tissue nitrite and nitrate concentrations were measured by modified micro-assay according to the method of <xref ref-type="bibr" rid="bibr37-0748233711416948">Vodovotz (1996)</xref>. Briefly, nitrate was reduced to nitrite by cadmium. Nitrite was measured by Griess reaction.</p>
</sec>
<sec id="section7-0748233711416948">
<title>Malondialdhyde measurement</title>
<p>Serum and tissues malondialdehyde (MDA) was measured by thiobarbituric acid method as described by <xref ref-type="bibr" rid="bibr41-0748233711416948">Zima et al. (1995)</xref>. The reaction mixture in a total volume of 10 ml containing 0.2 ml of tissue homogenate or serum, 0.2 ml of 8.1% sodium dodecyl sulfate, 1.5 ml of 20% acetic acid, 1.5 ml of distilled water, and 5 ml of <italic>n</italic>-butanol and pyridine mixture were heated at 95°C for 60 minutes. The pink-colored chromogen formed by the reaction of 2-thiobarbituric acid with the breakdown products of MDA were read at 535 nm.</p>
</sec>
<sec id="section8-0748233711416948">
<title>Assay of SOD activity</title>
<p>The SOD activity was determined by the nitroblue tetrazolium (NBT) reduction method (<xref ref-type="bibr" rid="bibr15-0748233711416948">Flohe and Otting, 1984</xref>). A 0.1 ml of tissue supernatant was added to a reaction mixture containing 0.1 mM EDTA (200 μl), 0.12 mM riboflavin (50 μl), and 0.6 M phosphate buffer (pH 7.8) in a final volume of 3 ml. The optical density was measured at 560 nm. The activity was expressed as U/min/mg protein.</p>
</sec>
<sec id="section9-0748233711416948">
<title>Assay of CAT activity</title>
<p>Catalase activity was determined according to the method <xref ref-type="bibr" rid="bibr7-0748233711416948">Claiborne (1985)</xref>. The reaction mixture (2 ml) contained 1.95 ml of 10 mM hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) in 60 mM phosphate buffer (pH 7.0). The reaction was started by adding 0.5 ml of tissue supernatant and the absorbance reading was taken at 240 nm after 3 minutes. Phosphate-buffered saline (60 mM, pH 7.0) was used as a reference. The data are expressed as μmol H<sub>2</sub>O<sub>2</sub> consumed/min/mg protein.</p>
</sec>
<sec id="section10-0748233711416948">
<title>Assay of GPx activity</title>
<p>Assay of GPx activity was based on the oxidation of GSH by cumene hydroperoxide. The activity of GPx was assayed by the method of Rotruck et al. (<xref ref-type="bibr" rid="bibr14-0748233711416948">Ellman, 1959</xref>). The reaction mixture containing 0.2 ml of EDTA (0.8 mM, pH 7.0), 0.4 ml of phosphate buffer (10 mM), and 0.2 ml of tissue homogenate or serum were incubated with 0.1 M of H<sub>2</sub>O<sub>2</sub> and 0.2 ml of GSH for 10 minutes. Oxidation of GSH by the enzyme was measured spectrophotometrically at 420 nm. The activity of GPx was expressed as μmol GSH oxidized/min/mg protein.</p>
</sec>
</sec>
<sec id="section11-0748233711416948">
<title>Histopathological examination</title>
<p>Mammary tissues were fixed in 10% buffered formalin, embedded in paraffin using a conventional automated system. The blocks were cut to obtain 5-μm thick sections and stained with hematoxylin–eosin (<xref ref-type="bibr" rid="bibr10-0748233711416948">Costa et al., 2002</xref>). The image of serial paraffin sections of each tissue were captured by light microscopy (Olympus BX51, Hamburg, Germany).</p>
</sec>
<sec id="section12-0748233711416948">
<title>Statistical analysis</title>
<p>Data were presented as the mean ± SD. One-way analysis of variance (ANOVA) followed by Tukey multiple comparison method was carried out to compare the mean value of different groups using SPSS 7.5 student version. Comparisons were made between group I versus groups II, III, and IV and group II versus groups III and IV. The <italic>p</italic> value &lt;0.05 was considered statistically significant in all cases. Correlation between variable data was determined by linear regression analysis.</p>
</sec>
</sec>
<sec id="section13-0748233711416948">
<title>Results</title>
<p>The body weight (BW) and the protection percentage in rats receiving either Lyco individually or combined with Toco is shown in <xref ref-type="table" rid="table1-0748233711416948">Table 1</xref>. The BW was significantly decreased in tumor-induced animals versus control (<italic>p</italic> &lt; 0.01) (<xref ref-type="table" rid="table1-0748233711416948">Table 1</xref>
). Conversely, supplementation of Lyco + Toco increased the BW of rats treated with Lyco alone compared to the control group. It was found that protection against DMBA-induced carcinogenesis in rats receiving Lyco alone was 70%, while it was 85% in animals that received Lyco with Toco as compared with nontreated rats. In the DMBA group, 5 out of 15 rats died (2 after 5 days and 3 after 75 days). In Lyco-treated group, 3 out of 12 rats died and in combined (Lyco + Toco) treatment 2 out of 15 rats died. In the DMBA group, there was severe inflammatory reaction on submandibular skin and development of multiple masses involving the mammary gland tissues.</p>
<table-wrap id="table1-0748233711416948" position="float">
<label>Table 1.</label>
<caption>
<p>Body weight and incidence of breast tumor in all studied groups (mean ± SD)</p>
</caption>
<graphic alternate-form-of="table1-0748233711416948" xlink:href="10.1177_0748233711416948-table1.tif"/>
<table>
<thead>
<tr>
<th>Groups</th>
<th>Group I</th>
<th>Group II</th>
<th>Group III</th>
<th>Group IV</th>
</tr>
</thead>
<tbody>
<tr>
<td>Parameters</td>
<td>Control (<italic>n</italic> = 15)</td>
<td>DMBA (<italic>n</italic> = 10)</td>
<td>DMBA + Lyco (<italic>n</italic> = 12)</td>
<td>DMBA + Lyco + Toco (<italic>n</italic> = 13)</td>
</tr>
<tr>
<td>Body weight, mean ± SD</td>
<td>190.5 ± 6.9</td>
<td>120.6 ± 5.1<sup>
<xref ref-type="table-fn" rid="table-fn2-0748233711416948">a</xref>
<xref ref-type="table-fn" rid="table-fn4-0748233711416948">c</xref>
</sup>
</td>
<td>150.2 ± 4.3<sup>
<xref ref-type="table-fn" rid="table-fn2-0748233711416948">a</xref>
<xref ref-type="table-fn" rid="table-fn4-0748233711416948">d</xref>,<xref ref-type="table-fn" rid="table-fn3-0748233711416948">b</xref>
<xref ref-type="table-fn" rid="table-fn5-0748233711416948">d</xref>
</sup>
</td>
<td>173.1 ± 5.6<sup>
<xref ref-type="table-fn" rid="table-fn2-0748233711416948">a</xref> NS,<xref ref-type="table-fn" rid="table-fn3-0748233711416948">b</xref>
<xref ref-type="table-fn" rid="table-fn4-0748233711416948">c</xref>
</sup>
</td>
</tr>
<tr>
<td>Incidence of tumor, mean ± SD</td>
<td>(0/12) 0%</td>
<td>10/10 (100%)<sup>
<xref ref-type="table-fn" rid="table-fn2-0748233711416948">a</xref>
<xref ref-type="table-fn" rid="table-fn6-0748233711416948">e</xref>
</sup>
</td>
<td>7/12 (58%)<sup>
<xref ref-type="table-fn" rid="table-fn2-0748233711416948">a</xref>
<xref ref-type="table-fn" rid="table-fn6-0748233711416948">e</xref>,<xref ref-type="table-fn" rid="table-fn3-0748233711416948">b</xref>
<xref ref-type="table-fn" rid="table-fn4-0748233711416948">c</xref>
</sup>
</td>
<td>3/13 (23%)<sup>
<xref ref-type="table-fn" rid="table-fn2-0748233711416948">a</xref> NS,<xref ref-type="table-fn" rid="table-fn3-0748233711416948">b</xref>
<xref ref-type="table-fn" rid="table-fn5-0748233711416948">d</xref>
</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0748233711416948">
<p>DMBA: 7,12-dimethylbenz[<italic>a</italic>]anthracene, Lyco: lycopene, Toco: tocopherol, NS: nonsignificant.</p>
</fn>
<fn id="table-fn2-0748233711416948">
<p>
<sup>a</sup>Groups II, III, and IV compared with control group I.</p>
</fn>
<fn id="table-fn3-0748233711416948">
<p>
<sup>b</sup>Groups III and IV compared with control group II.</p>
</fn>
<fn id="table-fn4-0748233711416948">
<p>
<sup>c</sup>
<italic>p</italic> &lt; 0.01.</p>
</fn>
<fn id="table-fn5-0748233711416948">
<p>
<sup>d</sup>
<italic>p</italic> &lt; 0.05.</p>
</fn>
<fn id="table-fn6-0748233711416948">
<p>
<sup>e</sup>
<italic>p</italic> &lt; 0.001.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Both MDA and nitric oxide (NO) levels in serum and breast tissues were increased statistically significantly in the rats with cancer; whereas, little reduction was found in the rats treated with Lyco, and much reduction in combined treatment (<italic>p</italic> &lt; 0.01) as compared with nontreated rats (<xref ref-type="table" rid="table2-0748233711416948">Table 2</xref>
).</p>
<table-wrap id="table2-0748233711416948" position="float">
<label>Table 2.</label>
<caption>
<p>Malondialdhyde (MDA) and nitric oxide (NO) levels in serum and tissues of all studied groups (mean ± SD)</p>
</caption>
<graphic alternate-form-of="table2-0748233711416948" xlink:href="10.1177_0748233711416948-table2.tif"/>
<table>
<thead>
<tr>
<th>Groups</th>
<th>Group I</th>
<th>Group II</th>
<th>Group III</th>
<th>Group IV</th>
</tr>
</thead>
<tbody>
<tr>
<td>Parameters</td>
<td>Control (<italic>n</italic> = 15)</td>
<td>DMBA (<italic>n</italic> = 10)</td>
<td>DMBA + Lyco (<italic>n</italic> = 12)</td>
<td>DMBA + Lyco + Toco (<italic>n</italic> = 13)</td>
</tr>
<tr>
<td>Serum MDA (nmol/ml)</td>
<td>10.2 ± 0.6</td>
<td>17 ± 2.1<sup>
<xref ref-type="table-fn" rid="table-fn8-0748233711416948">a</xref>
<xref ref-type="table-fn" rid="table-fn10-0748233711416948">c</xref>
</sup>
</td>
<td>13.3 ± 0.9<sup>
<xref ref-type="table-fn" rid="table-fn8-0748233711416948">a</xref>
<xref ref-type="table-fn" rid="table-fn11-0748233711416948">d</xref>,<xref ref-type="table-fn" rid="table-fn9-0748233711416948">b</xref>
<xref ref-type="table-fn" rid="table-fn11-0748233711416948">d</xref>
</sup>
</td>
<td>10.8 ± 0.5<sup>
<xref ref-type="table-fn" rid="table-fn8-0748233711416948">a</xref> NS,<xref ref-type="table-fn" rid="table-fn9-0748233711416948">b</xref>
<xref ref-type="table-fn" rid="table-fn12-0748233711416948">e</xref>
</sup>
</td>
</tr>
<tr>
<td>Tissue MDA (nmol/mg protein)</td>
<td>16.3 ± 0.2</td>
<td>21.1 ± 0.51<sup>
<xref ref-type="table-fn" rid="table-fn8-0748233711416948">a</xref>
<xref ref-type="table-fn" rid="table-fn12-0748233711416948">e</xref>
</sup>
</td>
<td>19.2 ± 0.4<sup>
<xref ref-type="table-fn" rid="table-fn8-0748233711416948">a</xref>
<xref ref-type="table-fn" rid="table-fn12-0748233711416948">e</xref>,<xref ref-type="table-fn" rid="table-fn9-0748233711416948">b</xref>
<xref ref-type="table-fn" rid="table-fn11-0748233711416948">d</xref>
</sup>
</td>
<td>16.9 ± 0.31<sup>
<xref ref-type="table-fn" rid="table-fn8-0748233711416948">a</xref> NS,<xref ref-type="table-fn" rid="table-fn9-0748233711416948">b</xref>
<xref ref-type="table-fn" rid="table-fn12-0748233711416948">e</xref>
</sup>
</td>
</tr>
<tr>
<td>Serum NO (μmol/L)</td>
<td>55.3 ± 6.1</td>
<td>120.1 ± 8<sup>
<xref ref-type="table-fn" rid="table-fn8-0748233711416948">a</xref>
<xref ref-type="table-fn" rid="table-fn12-0748233711416948">e</xref>
</sup>
</td>
<td>82.5 ± 6.9<sup>
<xref ref-type="table-fn" rid="table-fn8-0748233711416948">a</xref>
<xref ref-type="table-fn" rid="table-fn11-0748233711416948">d</xref>,<xref ref-type="table-fn" rid="table-fn9-0748233711416948">b</xref>
<xref ref-type="table-fn" rid="table-fn11-0748233711416948">d</xref>
</sup>
</td>
<td>85.8 ± 5.5<sup>
<xref ref-type="table-fn" rid="table-fn8-0748233711416948">a</xref> NS,<xref ref-type="table-fn" rid="table-fn9-0748233711416948">b</xref>
<xref ref-type="table-fn" rid="table-fn12-0748233711416948">e</xref>
</sup>
</td>
</tr>
<tr>
<td>Tissue NO (nmol/mg protein)</td>
<td>9.9 ± 0.3</td>
<td>19.1 ± 3.5<sup>
<xref ref-type="table-fn" rid="table-fn8-0748233711416948">a</xref>
<xref ref-type="table-fn" rid="table-fn10-0748233711416948">c</xref>
</sup>
</td>
<td>15.3 ± 1.9<sup>
<xref ref-type="table-fn" rid="table-fn8-0748233711416948">a</xref>
<xref ref-type="table-fn" rid="table-fn11-0748233711416948">d</xref>,<xref ref-type="table-fn" rid="table-fn9-0748233711416948">b</xref>
<xref ref-type="table-fn" rid="table-fn11-0748233711416948">d</xref>
</sup>
</td>
<td>10.8 ± 0.65<sup>
<xref ref-type="table-fn" rid="table-fn8-0748233711416948">a</xref> NS,<xref ref-type="table-fn" rid="table-fn9-0748233711416948">b</xref>
<xref ref-type="table-fn" rid="table-fn12-0748233711416948">e</xref>
</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn7-0748233711416948">
<p>DMBA: 7,12-dimethylbenz[<italic>a</italic>]anthracene, Lyco: lycopene, Toco: tocopherol, NS: nonsignificant.</p>
</fn>
<fn id="table-fn8-0748233711416948">
<p>
<sup>a</sup>Groups II, III, and IV compared with control group I.</p>
</fn>
<fn id="table-fn9-0748233711416948">
<p>
<sup>b</sup>Groups III and IV compared with control group II.</p>
</fn>
<fn id="table-fn10-0748233711416948">
<p>
<sup>c</sup>
<italic>p</italic> &lt; 0.001.</p>
</fn>
<fn id="table-fn11-0748233711416948">
<p>
<sup>d</sup>
<italic>p</italic> &lt; 0.05.</p>
</fn>
<fn id="table-fn12-0748233711416948">
<p>
<sup>e</sup>
<italic>p</italic> &lt; 0.01.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>There was a significant elevation in the activities of SOD in the combined (Lyco + Toco) treatment group versus tumor-bearing rats compared to group treated with Lyco alone (<xref ref-type="table" rid="table3-0748233711416948">Table 3</xref>
). CAT activity was significantly (<italic>p</italic> &lt; 0.05) lower in animals with breast cancer versus the control group. Moreover, higher CAT activity was recorded in groups treated with Lyco + Toco than Lyco alone versus nontreated rats. GPx activity was significantly (<italic>p</italic> &lt; 0.01) high in the combined (Lyco + Toco) treatment group compared to the group of rats treated with than Lyco alone. The activity of GPx was reduced in tumor-bearing rats versus the normal group (<xref ref-type="table" rid="table3-0748233711416948">Table 3</xref>).</p>
<table-wrap id="table3-0748233711416948" position="float">
<label>Table 3.</label>
<caption>
<p>The activities of tissue superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) of all studied groups (mean ± SD)</p>
</caption>
<graphic alternate-form-of="table3-0748233711416948" xlink:href="10.1177_0748233711416948-table3.tif"/>
<table>
<thead>
<tr>
<th>Groups</th>
<th>Group I</th>
<th>Group II</th>
<th>Group III</th>
<th>Group IV</th>
</tr>
</thead>
<tbody>
<tr>
<td>Parameters</td>
<td>Control (<italic>n</italic> = 15)</td>
<td>DMBA (<italic>n</italic> = 10)</td>
<td>DMBA + Lyco (<italic>n</italic> = 12)</td>
<td>DMBA + Lyco + Toco (<italic>n</italic> = 13)</td>
</tr>
<tr>
<td>SOD (U/min/mg protein)</td>
<td>30.8 ± 3.1</td>
<td>18.3 ± 1.1<sup>
<xref ref-type="table-fn" rid="table-fn14-0748233711416948">a</xref>
<xref ref-type="table-fn" rid="table-fn16-0748233711416948">c</xref>
</sup>
</td>
<td>23.5 ± 2.3<sup>
<xref ref-type="table-fn" rid="table-fn14-0748233711416948">a</xref>
<xref ref-type="table-fn" rid="table-fn17-0748233711416948">d</xref>,<xref ref-type="table-fn" rid="table-fn15-0748233711416948">b</xref>
<xref ref-type="table-fn" rid="table-fn17-0748233711416948">d</xref>
</sup>
</td>
<td>28 ± 1.7.5<sup>
<xref ref-type="table-fn" rid="table-fn8-0748233711416948">a</xref> NS,<xref ref-type="table-fn" rid="table-fn15-0748233711416948">b</xref>
<xref ref-type="table-fn" rid="table-fn18-0748233711416948">e</xref>
</sup>
</td>
</tr>
<tr>
<td>CAT (μmol H<sub>2</sub>O<sub>2</sub> consumed/min/mg protein)</td>
<td>78.6 ± 9.3</td>
<td>50 ± 5.9<sup>
<xref ref-type="table-fn" rid="table-fn14-0748233711416948">a</xref>
<xref ref-type="table-fn" rid="table-fn17-0748233711416948">d</xref>
</sup>
</td>
<td>61 ± 6.1<sup>
<xref ref-type="table-fn" rid="table-fn14-0748233711416948">a</xref>
<xref ref-type="table-fn" rid="table-fn17-0748233711416948">d</xref>,<xref ref-type="table-fn" rid="table-fn15-0748233711416948">b</xref>
<xref ref-type="table-fn" rid="table-fn17-0748233711416948">d</xref>
</sup>
</td>
<td>69 ± 7.3<sup>
<xref ref-type="table-fn" rid="table-fn14-0748233711416948">a</xref> NS,<xref ref-type="table-fn" rid="table-fn15-0748233711416948">b</xref>
<xref ref-type="table-fn" rid="table-fn16-0748233711416948">c</xref>
</sup>
</td>
</tr>
<tr>
<td>GPx (µmol GSH utilized/min/mg protein)</td>
<td>12.6 ± 3.1</td>
<td>4.9 ± 1.8<sup>
<xref ref-type="table-fn" rid="table-fn14-0748233711416948">a</xref>
<xref ref-type="table-fn" rid="table-fn18-0748233711416948">e</xref>
</sup>
</td>
<td>7.3 ± 2<sup>
<xref ref-type="table-fn" rid="table-fn14-0748233711416948">a</xref>
<xref ref-type="table-fn" rid="table-fn17-0748233711416948">d</xref>,<xref ref-type="table-fn" rid="table-fn15-0748233711416948">b</xref>
<xref ref-type="table-fn" rid="table-fn17-0748233711416948">d</xref>
</sup>
</td>
<td>11 ± 3.6<sup>
<xref ref-type="table-fn" rid="table-fn14-0748233711416948">a</xref> NS,<xref ref-type="table-fn" rid="table-fn15-0748233711416948">b</xref>
<xref ref-type="table-fn" rid="table-fn16-0748233711416948">c</xref>
</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn13-0748233711416948">
<p>DMBA: 7,12-dimethylbenz[<italic>a</italic>]anthracene, Lyco: lycopene, Toco: tocopherol, NS: nonsignificant.</p>
</fn>
<fn id="table-fn14-0748233711416948">
<p>
<sup>a</sup>Groups II, III, and IV compared with control group I.</p>
</fn>
<fn id="table-fn15-0748233711416948">
<p>
<sup>b</sup>Groups III and IV compared with control group II.</p>
</fn>
<fn id="table-fn16-0748233711416948">
<p>
<sup>c</sup>
<italic>p</italic> &lt; 0.01.</p>
</fn>
<fn id="table-fn17-0748233711416948">
<p>
<sup>d</sup>
<italic>p</italic> &lt; 0.05.</p>
</fn>
<fn id="table-fn18-0748233711416948">
<p>
<sup>e</sup>
<italic>p</italic> &lt; 0.001.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec id="section14-0748233711416948">
<title>Histological examination</title>
<p>Histological examination revealed that DMBA induced invasive breast lesions compared with DMBA treated with Lyco and Toco. The mammary gland tissues in control group formed of an admixture of fibro fatty tissues and ductal structures showed development of carcinoma in DMBA injected group. This was evident by neovasularization, presence of uniformly malignant ductal epithelial cells growing in vague cribiform pattern, necrosis formation along the tumor, and cell destructions. DMBA group treated with Lyco showed absence of the malignant changes with normal appearance of ductal tissues, and treatment with Lyco + Toco resulted in complete disappearance of abnormal changes caused by DMBA.</p>
</sec>
</sec>
<sec id="section15-0748233711416948">
<title>Discussion</title>
<p>A new strategy was developed for antineoplastic and free radical scavenging properties of various phytotherapeutic origins (<xref ref-type="bibr" rid="bibr33-0748233711416948">Ramar et al., 2006</xref>). The available semisynthetic anticancer drugs have more side effects and are cytotoxic to human beings. Since modern medicine has no effective cure for the malignant cancers and tumors, scientists are interested in finding a potent phototherapeutic agent with noncytotoxic properties.</p>
<p>The DMBA-induced mammary gland mimics some aspects of human disease and enables investigators to elucidate host factor influences on the initiation and promotion of breast cancer (<xref ref-type="bibr" rid="bibr29-0748233711416948">Kaufmann et al., 2008</xref>). DMBA has been widely used as an animal model for the development of chemopreventive drugs to cure breast cancer in humans (<xref ref-type="bibr" rid="bibr31-0748233711416948">Mehta, 2000</xref>). Data of the present study indicated that daily intake of Lyco alone or combined with Toco could prevent or delay the development of breast cancer in rat. The effects are highly significant, because fewer of the Lyco-supplemented animals (7 of12) developed tumor versus DMBA group and much lower (3 of 13) in combined treatment group. Also Lyco + Toco treatment decreases the number and size of tumors induced by the carcinogen (<xref ref-type="table" rid="table1-0748233711416948">Table 1</xref>).</p>
<p>The DMBA requires metabolic activation by cytochrome P450 to form diol epoxide and other ROS that are known to increase intracellular oxidation (<xref ref-type="bibr" rid="bibr21-0748233711416948">Guerin, 1978</xref>). Metabolism of DMBA by the mixed function oxidases system often results in the formation of oxyradicals ‘O<sub>2</sub>
<bold>ċ</bold>−, H<sub>2</sub>O<sub>2</sub>, <bold>ċ</bold>OH,’ which bind covalently to nucleophilic sites on cellular macromolecules, thereby eliciting cancerous responses (<xref ref-type="bibr" rid="bibr19-0748233711416948">Giri et al., 1995</xref>). The generation of ROS and the peroxidation of membrane lipids are well associated with the initiation of carcinogenesis affecting the normal biochemical process, which further leads to the reduction in BW (<xref ref-type="bibr" rid="bibr12-0748233711416948">Davis and Kuttan, 2001</xref>). This is in accordance with our results which revealed a significant reduction in BW as a result of DMBA administration. Serum and tissue MDA and NO levels increased significantly in the rats with breast cancer; their levels showed little reduction in the groups treated with Lyco alone and much reduction when combined with Toco; it was near to the normal in the control group. The reduction in NO level in combined treatment may be due to the inhibition of NO synthase enzyme as described by <xref ref-type="bibr" rid="bibr25-0748233711416948">Hussein et al. (2005)</xref>. In the DMBA group, a negative significant correlation was found between weight and serum NO (<italic>r</italic> = −0.71), and a positive significant correlation was found between NO and MDA (<italic>r</italic> = 0.92).</p>
<p>Oxidative stress due to the generation of free radicals and/or decreased antioxidant level in the target cells and tissues have been suggested to play an important role in carcinogenesis (<xref ref-type="bibr" rid="bibr24-0748233711416948">Huang et al., 1999</xref>). During cell membrane damage, various enzymes leak down to the circulatory fluid and their assessment in serum serves as markers in clinical studies. SOD is a major intracellular enzyme, which protects against oxygen free radicals by catalyzing the dismutation of superoxide free radical and anions to H<sub>2</sub>O<sub>2</sub> and oxygen. Catalase is an enzyme which is present in most cells and which catalyses the decomposition of H<sub>2</sub>O<sub>2</sub> to water and oxygen. GPx is an equally important antioxidant, which reacts with H<sub>2</sub>O<sub>2</sub>, thus preventing intracellular damage caused by the same (<xref ref-type="bibr" rid="bibr6-0748233711416948">Cerutti et al., 1994</xref>; <xref ref-type="bibr" rid="bibr22-0748233711416948">Gupta et al., 2004</xref>; <xref ref-type="bibr" rid="bibr38-0748233711416948">Weydert et al., 2006</xref>).</p>
<p>Vitamin E has been reported to be one of the most potent free radical scavengers, which significantly reduce free radical-induced chemical damages to DNA and membrane lipids (<xref ref-type="bibr" rid="bibr8-0748233711416948">Claycombe and Meydani, 2001</xref>). Vitamin E is lipophilic which has been found to scavenge various free radicals and effectively protect DNA and membranes against ionizing radiation (<xref ref-type="bibr" rid="bibr28-0748233711416948">Kapoor et al., 2002</xref>).</p>
<p>The present study revealed that SOD activity was decreased in the animals with cancer, which may be due to altered antioxidant status caused by carcinogenesis. Decrease in CAT activity was measured in patients with breast cancer and benign breast disease conditions (<xref ref-type="bibr" rid="bibr20-0748233711416948">Gonenc et al., 2006</xref>). This is in accordance with our results that indicate a decreased CAT in animals with cancer may be due to the utilization of antioxidant enzymes in the removal of H<sub>2</sub>O<sub>2</sub> released. GPx is an important defense enzyme against oxidative damage and this in turn requires GSH as a cofactor. GPx catalyses the oxidation of GSH to GSSG at the expense of H<sub>2</sub>O<sub>2</sub> (<xref ref-type="bibr" rid="bibr6-0748233711416948">Cerutti et al., 1994</xref>). Decreased GPx activity was also observed in cancerous conditions (<xref ref-type="bibr" rid="bibr2-0748233711416948">Bewick et al., 1987</xref>). Our findings agree well with this observation and also the activity of GPx significantly decreased in animals with cancer. CAT activity was significantly higher in the combination treatment group versus those treated with Lyco alone.</p>
<p>The combination treatment showed a significant reduction in tumors at the molecular level versus the cancer controls. Biochemical analysis revealed that combination treatment significantly inhibited lipid peroxidation, thus suggesting the antioxidant mechanism of Lyco when combined with Toco. The combination treatment may be useful in the prevention of breast cancer.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure" id="fn1-0748233711416948">
<p>The authors would like to thank Prof. Dr Taha Koumosani, head of biochemistry, Faculty of Science, KAU, Jeddah, KSA for kindly facilitating supplies for this work.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aruoma</surname>
<given-names>OI</given-names>
</name>
</person-group> (<year>1994</year>) <article-title>Nutrition and health aspects of free radicals and antioxidants</article-title>. <source>Food Chemistry and Toxicology</source>
<volume>32</volume>
(<issue>7</issue>): <fpage>671</fpage>–<lpage>685</lpage>.</citation>
</ref>
<ref id="bibr2-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bewick</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Coutie</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Tudhope</surname>
<given-names>GR</given-names>
</name>
</person-group> (<year>1987</year>) <article-title>Superoxide dismutase, glutathione peroxidase and catalase in the red cells of patients with malignant lymphoma</article-title>. <source>British Journal of Haematology</source>
<volume>65</volume>
(<issue>3</issue>): <fpage>347</fpage>–<lpage>350</lpage>.</citation>
</ref>
<ref id="bibr3-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burton</surname>
<given-names>GW</given-names>
</name>
</person-group> (<year>1994</year>) <article-title>Vitamin E: molecular and biological function</article-title>. <source>Proceedings of the Nutrition Society</source>
<volume>53</volume>
(<issue>2</issue>): <fpage>251</fpage>–<lpage>262</lpage>.</citation>
</ref>
<ref id="bibr4-0748233711416948">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Carpenter</surname>
<given-names>MP</given-names>
</name>
</person-group> (<year>1991</year>) <article-title>Vitamin E and C in neoplastic development</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Laidlaw</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Swendseid</surname>
<given-names>ME</given-names>
</name>
</person-group> (eds) <source>Vitamins and Cancer Prevention</source>. <publisher-loc>NY</publisher-loc>: <publisher-name>Wiley-Liss Inc</publisher-name>., <fpage>61</fpage>–<lpage>90</lpage>.</citation>
</ref>
<ref id="bibr5-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cerutti</surname>
<given-names>PA</given-names>
</name>
</person-group> (<year>1985</year>) <article-title>Prooxidant states and tumor promotion</article-title>. <source>Science</source>
<volume>227</volume>
(<issue>4685</issue>): <fpage>375</fpage>–<lpage>381</lpage>.</citation>
</ref>
<ref id="bibr6-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cerutti</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Oya</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Amstad</surname>
<given-names>P</given-names>
</name>
</person-group> (<year>1994</year>) <article-title>The role of cellular antioxidant defence in oxidant carcinogenesis</article-title>. <source>Environmental Health Perspectives</source>
<volume>102</volume>
(<issue>10</issue>): <fpage>123</fpage>–<lpage>129</lpage>.</citation>
</ref>
<ref id="bibr7-0748233711416948">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Claiborne</surname>
<given-names>A</given-names>
</name>
</person-group> (<year>1985</year>) <article-title>Catalase activity</article-title>. In <person-group person-group-type="editor">
<name>
<surname>Greenwald</surname>
<given-names>RA</given-names>
</name>
</person-group> (ed.) <source>CRC Handbook of Methods for Oxygen Radical Research</source>. <publisher-loc>Boca Raton, FL</publisher-loc>: <publisher-name>CRC Press</publisher-name>, <fpage>283</fpage>–<lpage>284</lpage>.</citation>
</ref>
<ref id="bibr8-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Claycombe</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Meydani</surname>
<given-names>SN</given-names>
</name>
</person-group> (<year>2001</year>) <article-title>Vitamin E and genome stability, α-tocopherol</article-title>. <source>Mutation Research</source>
<volume>475</volume>
(<issue>1–2</issue>): <fpage>37</fpage>.</citation>
</ref>
<ref id="bibr9-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clinton</surname>
<given-names>SK</given-names>
</name>
</person-group> (<year>1998</year>) <article-title>Lycopene: chemistry, biology, and implications for human health and disease</article-title>. <source>Nutrition Review</source>
<volume>56</volume>
(<issue>1 pt 1</issue>): <fpage>35</fpage>–<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr10-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costa</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Solanas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Escrich</surname>
<given-names>E</given-names>
</name>
</person-group> (<year>2002</year>) <article-title>Histopathologic characterization of mammary neoplastic lesions induced with 7,12- dimethylbenz(<italic>a</italic>)anthracene in the rat. A comparative analysis with human breast tumor</article-title>. <source>Archives of Pathology and Laboratory Medicine</source>
<volume>126</volume>
(<issue>8</issue>): <fpage>915</fpage>–<lpage>927</lpage>.</citation>
</ref>
<ref id="bibr11-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname>
<given-names>S</given-names>
</name>
</person-group> (<year>1994</year>) <article-title>Vitamin E in the genesis and prevention of cancer</article-title>. <source>Acta Oncologica</source>
<volume>33</volume>
(<issue>6</issue>): <fpage>615</fpage>–<lpage>619</lpage>.</citation>
</ref>
<ref id="bibr12-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kuttan</surname>
<given-names>G</given-names>
</name>
</person-group> (<year>2001</year>) <article-title>Effect of <italic>Withania somnifera</italic> on DMBA induced carcinogenesis</article-title>. <source>Journal of Ethanopharmacology</source>
<volume>75</volume>
(<issue>2–3</issue>): <fpage>165</fpage>–<lpage>168</lpage>.</citation>
</ref>
<ref id="bibr13-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duthe</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>AR</given-names>
</name>
</person-group> (<year>1996</year>) <article-title>Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes</article-title>. <source>Cancer Research</source>
<volume>56</volume>
(<issue>6</issue>): <fpage>1291</fpage>–<lpage>1295</lpage>.</citation>
</ref>
<ref id="bibr14-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellman</surname>
<given-names>GL</given-names>
</name>
</person-group> (<year>1959</year>) <article-title>Tissue sulfhydryl groups</article-title>. <source>Archives of Biochemistry and Biophysics</source>
<volume>82</volume>
(<issue>1</issue>): <fpage>70</fpage>–<lpage>77</lpage>.</citation>
</ref>
<ref id="bibr15-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flohe</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Otting</surname>
<given-names>F</given-names>
</name>
</person-group> (<year>1984</year>) <article-title>Superoxide dismutase assays</article-title>. <source>Methods in Enzymology</source>
<volume>105</volume>: <fpage>93</fpage>–<lpage>104</lpage>.</citation>
</ref>
<ref id="bibr16-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fuhramn</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Elis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Aviram</surname>
<given-names>M</given-names>
</name>
</person-group> (<year>1997</year>) <article-title>Hypocholesterolemic effect of lycopene and ᵦ-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophage</article-title>. <source>Biochemical and Biophysical Research Communications</source>
<volume>233</volume>
(<issue>3</issue>): <fpage>658</fpage>–<lpage>662</lpage>.</citation>
</ref>
<ref id="bibr17-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gerster</surname>
<given-names>H</given-names>
</name>
</person-group> (<year>1997</year>) <article-title>The potential role of lycopene for human health</article-title>. <source>Journal of American College of Nutrition</source>
<volume>16</volume>
(<issue>2</issue>): <fpage>109</fpage>–<lpage>126</lpage>.</citation>
</ref>
<ref id="bibr18-0748233711416948">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Gilbert</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Colton</surname>
<given-names>CA</given-names>
</name>
</person-group> (<year>1999</year>) <source>Reactive Oxygen Species in Biological Systems: An Interdisciplinary Approach</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Kluwer Academic/Plenum Publishers</publisher-name>.</citation>
</ref>
<ref id="bibr19-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giri</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Abdulla</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Athar</surname>
<given-names>M</given-names>
</name>
</person-group> (<year>1995</year>) <article-title>Evidence that in situ generated reactive oxygen species act as a potent stage I tumor promoter in mouse skin</article-title>. <source>Biochemical and Biophysical Research Communication</source>
<volume>209</volume>
(<issue>2</issue>): <fpage>698</fpage>–<lpage>705</lpage>.</citation>
</ref>
<ref id="bibr20-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonenc</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Erten</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Aslan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Akyncy</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sximsxek</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Torun</surname>
<given-names>M</given-names>
</name>
</person-group> (<year>2006</year>) <article-title>Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumour and benign breast disease</article-title>. <source>Cell Biology International</source>
<volume>30</volume>
(<issue>4</issue>): <fpage>376</fpage>–<lpage>380</lpage>.</citation>
</ref>
<ref id="bibr21-0748233711416948">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Guerin</surname>
<given-names>MR</given-names>
</name>
</person-group> (<year>1978</year>) <article-title>Energy sources of polycyclic aromatic hydrocarbons</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Gelboin</surname>
<given-names>HV</given-names>
</name>
<name>
<surname>Ts'o</surname>
<given-names>POP</given-names>
</name>
</person-group> (eds) <source>Polycyclic Hydrocarbons and Cancer: Chemistry, Molecular Biology and Environment</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Academic Press</publisher-name>, <fpage>1</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr22-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mazumder</surname>
<given-names>UK</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Sivakumar</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Vamsi</surname>
<given-names>ML</given-names>
</name>
</person-group> (<year>2004</year>) <article-title>Antitumour activity and antioxidant status of Caesalpina Bonducella against Ehrlich ascites carcinoma in swiss albino mice</article-title>. <source>Journal of Pharmacological Sciences</source>
<volume>94</volume>
(<issue>2</issue>): <fpage>177</fpage>–<lpage>184</lpage>.</citation>
</ref>
<ref id="bibr23-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henry</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Narendra</surname>
<given-names>PS</given-names>
</name>
</person-group> (<year>2006</year>) <article-title>Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat</article-title>. <source>Cancer Letters</source>
<volume>231</volume>
(<issue>1</issue>): <fpage>43</fpage>–<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr24-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Sheu</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>TH</given-names>
</name>
</person-group> (<year>1999</year>) <article-title>Association between oxidative stress and changes of trace elements in patients with breast cancer</article-title>. <source>Clinical Biochemistry</source>
<volume>32</volume>
(<issue>2</issue>): <fpage>131</fpage>–<lpage>136</lpage>.</citation>
</ref>
<ref id="bibr25-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hussein</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Abu-Dief</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Abdel Reheem</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Abdel Rahman</surname>
<given-names>A</given-names>
</name>
</person-group> (<year>2005</year>) <article-title>Ultra structural evaluation of the radio protective effects of melatonin against X-ray induced skin damage in albino rats</article-title>. <source>International Journal of Experimental Pathology</source>
<volume>86</volume>
(<issue>1</issue>): <fpage>45</fpage>–<lpage>55</lpage>.</citation>
</ref>
<ref id="bibr26-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jagetia</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>SK</given-names>
</name>
</person-group> (<year>2006</year>) <article-title>Evaluation of the antineoplastic activity of guduchi (<italic>Tinospora cordifolia</italic>) in <italic>Ehrlich ascites</italic> carcinoma bearing mice</article-title>. <source>Biological and Pharmaceutical Bulletin</source>
<volume>29</volume>
(<issue>3</issue>): <fpage>460</fpage>–<lpage>466</lpage>.</citation>
</ref>
<ref id="bibr27-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joseph</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Michael</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wieslawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Seth</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zhonglin</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>AC</given-names>
</name>
</person-group> (<year>2001</year>) <article-title>Effects of a lycopene-rich diet on spontaneous and benzo[a]pyrene-induced mutagenesis in prostate, colon and lungs of the lacZ mouse</article-title>. <source>Cancer Letters</source>
<volume>164</volume>
(<issue>1</issue>): <fpage>1</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr28-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kapoor</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kagiya</surname>
<given-names>VT</given-names>
</name>
<name>
<surname>Nair</surname>
<given-names>CK</given-names>
</name>
</person-group> (<year>2002</year>) <article-title>Redox reactions of tocopherol monoglucoside in aqueous solutions: a pulse radiolysis study</article-title>. <source>Journal of Radiation Research</source>
<volume>43</volume>
(<issue>1</issue>): <fpage>99</fpage>–<lpage>106</lpage>.</citation>
</ref>
<ref id="bibr29-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaufmann</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Spring</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Klimberg</surname>
<given-names>VS</given-names>
</name>
</person-group> (<year>2008</year>) <article-title>Oral glutamine prevents DMBA-induced mammary carcinogenesis via upregulation of glutathione production. Basic nutritional investigation</article-title>. <source>Nutrition</source>
<volume>24</volume>
(<issue>5</issue>): <fpage>462</fpage>–<lpage>469</lpage>.</citation>
</ref>
<ref id="bibr30-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Machlin</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Bendich</surname>
<given-names>A</given-names>
</name>
</person-group> (<year>1987</year>) <article-title>Free radical tissue damage: protective role of antioxidant nutrients</article-title>. <source>FASEB Journal</source>
<volume>1</volume>
(<issue>6</issue>): <fpage>441</fpage>–<lpage>445</lpage>.</citation>
</ref>
<ref id="bibr31-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mehta</surname>
<given-names>RG</given-names>
</name>
</person-group> (<year>2000</year>) <article-title>Experimental basis for the prevention of breast cancer</article-title>. <source>European Journal of Cancer</source>
<volume>36</volume>
(<issue>10</issue>): <fpage>1275</fpage>–<lpage>1282</lpage>.</citation>
</ref>
<ref id="bibr32-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moselhy</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Almslmani</surname>
<given-names>MA</given-names>
</name>
</person-group> (<year>2008</year>) <article-title>Chemopreventive effect of Lyco alone or with melatonin against the genesis of oxidative stress and mammary tumors induced by 7,12 dimethyl(a)benzanthracene in Sprague Dawley female rats</article-title>. <source>Molecular Cellular Biochemistry</source>
<volume>319</volume>
(<issue>1–2</issue>): <fpage>175</fpage>–<lpage>180</lpage>.</citation>
</ref>
<ref id="bibr33-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramar</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Ponnampalam</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Savarimuthu</surname>
<given-names>I</given-names>
</name>
</person-group> (<year>2006</year>) <article-title>Anti-tumor promoting potential of luteolin against 7,12-dimethylbenz(<italic>a</italic>)anthracene-induced mammary tumors in rats</article-title>. <source>Chemico-Biological Interactions</source>
<volume>164</volume>
(<issue>1–2</issue>): <fpage>1</fpage>–<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr34-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rao</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Agarwal</surname>
<given-names>S</given-names>
</name>
</person-group> (<year>1999</year>) <article-title>Role of lycopene as antioxidant carotenoids in the prevention of chronic diseases: a review</article-title>. <source>Nutrition Research</source>
<volume>19</volume>
(<issue>2</issue>): <fpage>305</fpage>–<lpage>323</lpage>.</citation>
</ref>
<ref id="bibr35-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sesso</surname>
<given-names>HD</given-names>
</name>
<name>
<surname>Buring</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Norkus</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Gaziano</surname>
<given-names>JM</given-names>
</name>
</person-group> (<year>2005</year>) <article-title>Dietary and plasma lycopene and the risk of breast cancer</article-title>. <source>Cancer Epidemiology, Biomarkers and Prevention</source>
<volume>14</volume>
(<issue>5</issue>): <fpage>1074</fpage>–<lpage>1081</lpage>.</citation>
</ref>
<ref id="bibr36-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vijayavel</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Anbuselvam</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Balasubramanian</surname>
<given-names>MP</given-names>
</name>
</person-group> (<year>2006</year>) <article-title>Free radical scavenging activity of the marine mangrove <italic>Rhizophora apiculata</italic> bark extract with reference to naphthalene induced mitochondrial dysfunction</article-title>. <source>Chemico-Biological Interactions</source>
<volume>163</volume>
(<issue>1–2</issue>): <fpage>170</fpage>–<lpage>175</lpage>.</citation>
</ref>
<ref id="bibr37-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vodovotz</surname>
<given-names>Y</given-names>
</name>
</person-group> (<year>1996</year>) <article-title>Modified microassay for serum nitrite and nitrate</article-title>. <source>Biotechniques</source>
<volume>20</volume>
(<issue>3</issue>): <fpage>390</fpage>–<lpage>394</lpage>.</citation>
</ref>
<ref id="bibr38-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weydert</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Waugh</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Ritchie</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Iyer</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>. (<year>2006</year>) <article-title>Over expression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth</article-title>. <source>Free Radical Biology and Medicine</source>
<volume>41</volume>
(<issue>2</issue>): <fpage>226</fpage>–<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr39-0748233711416948">
<citation citation-type="book">
<collab collab-type="author">World Health Organization</collab> (<year>2006</year>) <article-title>Fact sheet No. 297. Cancer</article-title>.</citation>
</ref>
<ref id="bibr40-0748233711416948">
<citation citation-type="book">
<collab collab-type="author">World Health Organization International Agency for Research on Cancer</collab> (<year>2003</year>). <article-title>World cancer report</article-title>.</citation>
</ref>
<ref id="bibr41-0748233711416948">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zima</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Stipek</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Crkovska</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Platenik</surname>
</name>
</person-group> (<year>1995</year>) <article-title>Measurement of lipid peroxidation products in biological samples by spectrophotometric and HPLC assay</article-title>. <source>Clinical Biochemistry and Metabolism</source>
<volume>3</volume>
(<issue>24</issue>): <fpage>98</fpage>–<lpage>102</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>